Skip to Main Content

Good morning, everyone, and how are you today? We are just fine, thank you, especially as our shortest person has now begun an honest-to-goodness summer job, adding to the sunny outlook of economists everywhere. This calls for a celebratory cup of stimulation and, as always, we invite you to join us. And why not? Firing up some neurons may be a plus. Meanwhile, here are some items of interest. Having a smashing day and do keep in touch …

Prosecutors and defense lawyers went through 134 potential jurors on Monday and failed to find one to sit and judge Martin Shkreli, with many calling him a “snake,” “evil,” and a “d–k,” The New York Post confides. “The defendant is the face of corporate greed in America,” one potential juror ​said. Shkreli is on trial for securities fraud, but is notorious for buying an old drug and jacking up the price to sky-high levels, and then taunting critics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • @Ed, perhaps evil is too strong a word. For example Hank McKinnell was a nice guy, but did manage a $188 million severance from Pfizer. He even managed to get paid for nearly 500 days of unused vacation.

  • Ed, they are going about the Shkreli jury selection process the wrong way. By law Pharma Bro is entitled to a jury of his peers. It should not be difficult to find 12 other evil greedy pharmaceutical executives to empanel a jury. I could probably fill the jury box in less than one day if they asked me.

Comments are closed.